Actively Recruiting

Age: 18Years - 80Years
All Genders
NCT06662071

A Research Protocol for Evaluating the Efficacy of Perfused Chemotherapeutic Agents for Bladder Cancer Based on Organoid Technology

Led by Qilu Hospital of Shandong University · Updated on 2024-10-28

293

Participants Needed

17

Research Sites

208 weeks

Total Duration

On this page

Sponsors

Q

Qilu Hospital of Shandong University

Lead Sponsor

T

The Second Hospital of Shandong University

Collaborating Sponsor

AI-Summary

What this Trial Is About

The investigators are here to invite participants to participate in a medical research project, and this informed consent form provides participants with information to decide whether or not to participate in this study. Please read the following carefully and discuss any questions and terms that are not clear with the study doctor. The participants' participation in this study is completely voluntary and the project has been reviewed by the Research Ethics Committee of Qilu Hospital, Shandong University.

CONDITIONS

Official Title

A Research Protocol for Evaluating the Efficacy of Perfused Chemotherapeutic Agents for Bladder Cancer Based on Organoid Technology

Who Can Participate

Age: 18Years - 80Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Age 18-80 years old, any gender
  • Patients with intermediate-risk and high-risk non-muscle invasive bladder cancer (NMIBC) needing bladder perfusion therapy
  • No prior bladder perfusion therapy except immediate postoperative perfusion
  • ECOG status score of 0-2
  • Able to follow the trial protocol and cooperate with adverse event observation and follow-up
  • Voluntarily agree to participate and have signed informed consent
Not Eligible

You will not qualify if you...

  • Bladder perforation during TURBT, postoperative gross hematuria, symptomatic severe chemical cystitis, or urinary tract infection
  • Immunodeficiency or immune system damage (e.g., AIDS, immunosuppressive drugs, radiotherapy)
  • Known allergies or sensitivities to the study drug or its components
  • Long-term use of hormonal drugs or history of drug abuse/dependence
  • Current pregnancy, breastfeeding, or plans for pregnancy soon
  • Abnormal blood counts, liver/kidney function, or coagulation indexes as defined
  • Previous or current myelodysplastic syndrome (MDS) or acute myeloid leukemia (AML)
  • History of significant neurological or psychiatric disorders
  • Serious medical conditions that threaten safety or interfere with study completion
  • Other serious diseases or social/family factors affecting safety or data collection
  • Uncontrolled co-morbidities including active infections, heart failure, unstable angina, or arrhythmias
  • Investigator judgment deeming participant unsuitable for the study

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 17 locations

1

Binzhou Medical University Hospital

Binzhou, Shandong, China

Actively Recruiting

2

Qilu Hospital of Shandong University Dezhou Hospital

Dezhou, Shandong, China

Actively Recruiting

3

Qilu Hospital of Shandong University

Jinan, Shandong, China, 250012

Actively Recruiting

4

Shandong Provincial Hospital Affiliated to Shandong First Medical University (Shandong Provincial Hospital)

Jinan, Shandong, China

Actively Recruiting

5

Shandong Third Hospital

Jinan, Shandong, China

Actively Recruiting

6

The First Affiliated Hospital Of Shandong First Medcial Unversity

Jinan, Shandong, China

Actively Recruiting

7

The second hospital of Shandong University

Jinan, Shandong, China

Actively Recruiting

8

Jining No.1 People's Hospital

Jining, Shandong, China

Actively Recruiting

9

Liaocheng People's Hospital

Liaocheng, Shandong, China

Actively Recruiting

10

Linyi People's Hospital

Linyi, Shandong, China

Actively Recruiting

11

Qilu Hospital of Shandong University(Qing Dao)

Qingdao, Shandong, China

Actively Recruiting

12

the Affiliated Hospital of Qingdao University

Qingdao, Shandong, China

Actively Recruiting

13

Taian City Central Hospital

Taian, Shandong, China

Actively Recruiting

14

Weifang People's Hospital

Weifang, Shandong, China

Actively Recruiting

15

Yantai Yuhuanding Hospital

Yantai, Shandong, China

Actively Recruiting

16

Zaozhuang Municipal Hospital

Zaozhuang, Shandong, China

Actively Recruiting

17

Zibo Central Hospital

Zibo, Shandong, China

Actively Recruiting

Loading map...

Research Team

J

Jun Chen

CONTACT

L

Lei Liu

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

3

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here